Tag: Betrixaban

Betrixaban is its own generic name, but it was formerly marketed under the brand name Bevyxxa. A notable fact about this medication is that it was voluntarily withdrawn from the market by its manufacturer in April 2020 for business reasons, not due to safety concerns.

In June 2020, Portola Pharmaceuticals conducted a market withdrawal of Betrixaban (Bevyxxa) for business reasons, not due to specific safety or quality concerns. This article explores the clinical trial data, market challenges, and regulatory hurdles that answer the question: **Why was Betrixaban discontinued?**